Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurocritical Care

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1385/NCC:6:1:3PMID 17356185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Vasodilatory Shock

  2012cited by this paper
• Optimizing blood pressure in neurological emergencies

  2006cited by this paper
• Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock

  2005cited by this paper
• Inter-examiner variability of Transcranial Doppler procedure and reports: a multicenter survey

  2005cited by this paper
• Arginine vasopressin in 316 patients with advanced vasodilatory shock*

  2005cited by this paper
• Optimizing blood pressure in neurological emergencies

  2004cited by this paper
• Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update

  2004cited by this paper
• A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.

  2004cited by this paper
• PARTICIPATION OF VASOPRESSIN IN THE DEVELOPMENT OF CEREBRAL VASOSPASM IN A RAT MODEL OF SUBARACHNOID HAEMORRHAGE

  2004influential reference
• Terlipressin for cerebral perfusion pressure support in a patient with septic shock

  2004cited by this paper
• Arginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled Study

  2003cited by this paper
• Early use of small-dose vasopressin for unstable hemodynamics in an acute brain injury patient refractory to catecholamine treatment: a case report.

  2003cited by this paper
• Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock

  2002influential reference
• Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

  2001cited by this paper
• The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series

  2001influential reference
• Prophylactic Hyperdynamic Postoperative Fluid Therapy after Aneurysmal Subarachnoid Hemorrhage: A Clinical, Prospective, Randomized, Controlled Study

  2001cited by this paper
• High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms

  2000cited by this paper
• , Hemorrhage : A Randomized Controlled Trial Effect of Hypervolemic Therapy on Cerebral Blood Flow After Subarachnoid

  2000cited by this paper
• Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.

  1999cited by this paper
• Low-dose vasopressin in the treatment of vasodilatory septic shock.

  1999cited by this paper
• The burden, trends, and demographics of mortality from subarachnoid hemorrhage

  1998cited by this paper
• A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.

  1997cited by this paper
• Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.

  1997cited by this paper
• Vasopressin pressor hypersensitivity in vasodilatory septic shock.

  1997cited by this paper
• Arginine Vasopressin Receptor Antagonists for Treatment of Vasogenic Brain Edema: An Experimental Study

  1996cited by this paper
• Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

  1995cited by this paper
• Expression and distribution of aquaporin of collecting duct are regulated by vasopressin V2 receptor in rat kidney.

  1994cited by this paper
• Effects of vasopressin on regional cerebral blood flow in dogs.

  1994cited by this paper
• Alterations in Plasma Concentrations of Natriuretic Peptides and Antidiuretic Hormone After Subarachnoid Hemorrhage

  1994cited by this paper
• Vasopressin mediated vasodilation of cerebral arteries.

  1994cited by this paper
• Effects of vasopressin and oxytocin on canine cerebral circulation in vivo.

  1992cited by this paper
• Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.

  1990cited by this paper
• Endothelium-dependent and -independent responses to vasodilators of isolated dog cerebral arteries.

  1988cited by this paper
• Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage.

  1988cited by this paper
• The role of vasopressin in acute cerebral vasospasm. Effect on spasm of a vasopressin antagonist or vasopressin antiserum.

  1988influential reference
• Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

  1985cited by this paper
• Vasopressin Causes Endothelium‐Dependent Relaxations of the Canine Basilar Artery

  1984cited by this paper
• Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage.

  1984cited by this paper
• Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension.

  1982cited by this paper
• Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

  1980influential reference
• Electrocardiographic changes in cerebrovascular hemorrhage.

  1980cited by this paper
• PATHOGENESIS OF NEUROGENIC PULMONARY ŒDEMA

  1975cited by this paper
• Assessment of outcome after severe brain damage.

  1975cited by this paper
• Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

  1968cited by this paper

• Effects of early high-dose vasopressor administration in patients after aneurysmal subarachnoid hemorrhage: a retrospective single-center study

  2025cites this paper
• The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review

  2023cites this paper
• Delayed cerebral ischemia and therapeutic approaches after subarachnoid hemorrhage

  2022cites this paper
• Healthcare expenditures associated with delayed cerebral ischemia following subarachnoid hemorrhage: a propensity-adjusted analysis.

  2022cites this paper
• Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A Case Series and Literature Review

  2021cites this paper
• Evaluation and Management of Cerebral Vasospasm after Subarachnoid Hemorrhage

  2021cites this paper
• Anaphylactic shock

  2020cites this paper
• Vasopressor treatment and mortality following nontraumatic subarachnoid hemorrhage: a nationwide electronic health record analysis.

  2020cites this paper
• Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage.

  2019cites this paper
• Elevated hemoglobin is associated with poor prognosis in Tibetans with poor-grade aneurysmal subarachnoid hemorrhage after clipping: A Retrospective Case-Control Study.

  2019cites this paper
• Cerebral vasospasm following subarachnoid hemorrhage (SAH)

  2018cites this paper
• Risk of Hyponatremia in Patients with Aneurysmal Subarachnoid Hemorrhage Treated with Exogenous Vasopressin Infusion

  2017cites this paper
• Mechanisms of Global Cerebral Edema Formation in Aneurysmal Subarachnoid Hemorrhage

  2017cites this paper
• Clinical analysis of the simultaneous clipping of bilateral middle cerebral artery aneurysms via the unilateral pterional approach

  2016cites this paper
• Management of delayed cerebral ischemia after subarachnoid hemorrhage

  2016cites this paper
• Rescue Therapy for Refractory Vasospasm after Subarachnoid Hemorrhage

  2014cites this paper
• Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

  2014cites this paper
• Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage

  2013cites this paper
• Hemodynamic Management of Subarachnoid Hemorrhage Miriam M. TreggiariParticipants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage

  2011cites this paper
• Hemodynamic Management of Subarachnoid Hemorrhage

  2011cites this paper
• Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond

  2008cites this paper